CZX

4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole

Find entries where: CZX

is present as a standalone ligand in 3 entries

Find related ligands:

Chemical Component Summary
Name	4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole
Identifiers	4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole
Formula	C₁₃ H₁₆ N₂
Molecular Weight	200.28
Type	NON-POLYMER
Isomeric SMILES	Cc1cccc(c1C)[C@H](C)c2c[nH]cn2
InChI	InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1
InChIKey	CUHVIMMYOGQXCV-NSHDSACASA-N

Chemical Details
Formal Charge	0
Atom Count	31
Chiral Atom Count	1
Bond Count	32
Aromatic Bond Count	11

Drug Info: DrugBank

DrugBank ID	DB00633
Name	Dexmedetomidine
Groups	vet_approved approved
Description	An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Synonyms	Dexmédétomidine Dexmedetomidin (+)-4-((S)-α,2,3-trimethylbenzyl)imidazole (+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole Dexmedetomidina Dexmedetomidine Dexmedetomidine hydrochloride Dexmedetomidinum
Brand Names	Dexmedetomidine Accord Dexmedetomidine Hydrochloride in Dextrose Dexmedetomidine hydrochloride Dexmedetomidine Hydrochloride for Injection, USP Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride Dexmedetomidine Hydrochloride in Sodium Chloride Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride Dexmedetomidine HCl Igalmi Precedex Dexmedetomidine HCI Chloride Dexmedetomidine Dexmedetomidine Hydrocholoride for Injection USP Precedex Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Dexdor Dexmedetomidine Hydrocholoride Injection Dexmedetomidine Hydrochloride for Injection
Indication	Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures.[L41374] It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.[L41379]
Categories	Adrenergic Agents Adrenergic Agonists Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Agents producing tachycardia Agents that produce hypertension Analgesics Analgesics, Non-Narcotic Anesthetics Anesthetics, General Bradycardia-Causing Agents Central alpha-2 Adrenergic Agonist Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Hypnotics and Sedatives Hypotensive Agents Imidazoles Miscellaneous Anxiolytics Sedatives and Hypnotics Nervous System Neurotransmitter Agents Peripheral Nervous System Agents Psycholeptics Sensory System Agents
ATC-Code	N05CM18
CAS number	113775-47-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Alpha-2A adrenergic receptor	MGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFG...	unknown	agonist
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	substrate
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	inhibitor
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	inhibitor
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682